SMALES KELLY sold 1.0% of their position (766.00 shares) of TRANSPHORM, INC. on the open market
Open‑market sale worth $3.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/5/2024ACC: 0001209191-24-001082
-766.00
Net shares
Net seller
$3.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
766.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−766.00
Price / share
$3.90
Trade value
$2.99K
% of position
1.0%
1/4/2024
77.45K→76.68K
Total
Net shares
−766.00
Net value
-$2.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/4/2024 | S · Sale | −766.00 | $3.90 | $2.99K | 1.0% | 77.45K | 76.68K |
| Total | −766.00 | -$2.99K | ||||||
Derivative Transactions0
No derivative transactions reported